Castle Biosciences Inc (CSTL) — Cash Flow Quality Index
Castle Biosciences Inc (CSTL) has a Cash Flow Quality Index of 4.60x as of June 2025. Operating cash flow of $20.82 Million exceeds net income of $4.52 Million, indicating high earnings quality where cash backs reported profits. Explore Castle Biosciences Inc (CSTL) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Castle Biosciences Inc Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Castle Biosciences Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CSTL intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Castle Biosciences Inc (2019–2024)
Year-by-year earnings quality comparison for Castle Biosciences Inc. For live market cap and the full company financial profile, see Castle Biosciences Inc stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 3.56x | $64.87 Million | $18.25 Million | ▲ +167.4% |
| 2019 | 1.33x | $7.01 Million | $5.28 Million | — |